M D DeMario - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M D DeMario

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998

Oral chemotherapy: rationale and future directionsM D DeMario, M J Ratain

Seminars in Oncology|September 5, 1998

Lymphomas in the immunocompromised patientM D DeMario, D N Liebowitz

Oncology (Williston Park, N.Y.)|February 12, 1998

Rationale for phase I study of UFT plus leucovorin and oral JM-216M D DeMario, M J Ratain

Cancer Chemotherapy and Pharmacology|April 1, 1999

A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 daysM D DeMario, M J Ratain, N J Vogelzang, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998

Oral chemotherapy: rationale and future directionsM D DeMario, M J Ratain

Seminars in Oncology|September 5, 1998

Lymphomas in the immunocompromised patientM D DeMario, D N Liebowitz

Oncology (Williston Park, N.Y.)|February 12, 1998

Rationale for phase I study of UFT plus leucovorin and oral JM-216M D DeMario, M J Ratain

Cancer Chemotherapy and Pharmacology|April 1, 1999

A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 daysM D DeMario, M J Ratain, N J Vogelzang, et al.

Pageof 1